SHAWNEE, Kan., June 1 /PRNewswire/ -- Bayer Corporation is introducing for
commercial development a third generation of hyaluronic acid (HA) that is
currently approved by FDA for intravenous and intraarticular use to treat
arthritis and degenerative joint disease in horses. Bayer is seeking
qualified customers interested in using its HA for product development in the
human medical field.
Bayer's HA is derived from patented processes using Streptococcus
fermentation in protein-free medium and purification steps that yield a pure,
hyaluronic acid, standardized by molecular weight and viscosity. Bayer's HA
differs from highly viscous HA extracted from rooster combs with potentially
reactive components and from other HA products derived from Streptococcus
fermentations that use media containing complex proteins.
Bayer is building a state-of-the-art hyaluronic acid manufacturing
facility designed to meet FDA cGMP regulations for both veterinary and human
uses. This facility is scheduled for validation activities in 1999 and will
be available for full production in 2000.
Parties interested in hyaluronic acid products should contact Larry
Williams, Manager, Contract Manufacturing, Bayer Corporation, 12707 Shawnee
Mission Parkway, Shawnee, KS 66201 or telephone 913-268-2128.
Bayer Corporation is a researched-based company with major businesses in
health care, life sciences and chemicals. The company had 1998 sales of
$8.1 billion and employs more than 23,000 people. Bayer Corporation is
investing $15 billion in capital expenditures and research and development
from 1995 through the year 2004. 1999 capital investment and R&D expenditures
are projected to total $1.6 billion. Bayer Corporation, with headquarters in
Pittsburgh, is a member of the worldwide Bayer Group, a $31 billion chemicals
and health care group based in Leverkusen, Germany.
SOURCE Bayer Corporation
 back to top
Related links:
http://www.bayerus.com
Company News On-Call:
http://www.prnewswire.com/comp/092575.html or fax,
800-758-5804, ext. 092575
CONTACT:
Larry Williams of Bayer, 913-268-2128
|
